Eureking SA is a France-based special purpose acquisition company (SPAC) formed with the aim of acquiring targets companies in the field of pharmaceutical industry. The Company intends to the European and fast-growing companies specializing in three business segments: the production of biological products, cell and gene therapies and live Biotherapeutics (with applications in the microbiome). The Biotherapies and technological solutions in the Biopharmaceutical companies are used to develop new treatments with both logistical and industrial support along with the tools and production capacity to pursue the clinical developments or to market the products.